Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 72.4% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

Close
Live Chat

Trade Novavax NVAX

Sell
 Buy

Novavax live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2025 Jan 21, 03:22

Novavax, Inc. (NVAX) Stock: The Under-the-Radar Stock Poised for Massive Upside in 2025

Novavax Inc
Webhose 2025 Jan 15, 00:00

Novavax (NVAX) Rises But Trails Market: What Investors Should Know - January 15, 2025 - Zacks.com

Novavax Inc
Webhose 2025 Jan 13, 19:12

JPMorgan's top short ideas for 2025

Novavax Inc
Webhose 2025 Jan 08, 18:21

Novavax (NASDAQ:NVAX) Stock Price Down 8.2% - Time to Sell?

Novavax Inc
Webhose 2025 Jan 08, 02:10

Vaccine stocks rise in premarket trading amid a jump in number of flu cases By Investing.com

Novavax Inc
Webhose 2025 Jan 08, 00:00

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - January 8, 2025 - Zacks.com

Novavax Inc
Webhose 2025 Jan 08, 00:00

Strength Seen in Novavax (NVAX): Can Its 10.9% Jump Turn into More Strength? - January 8, 2025 - Zacks.com

Novavax Inc
Webhose 2025 Jan 07, 23:14

Health Care Up as Vaccine Makers Surge - Health Care Roundup | Morningstar

Novavax Inc
Webhose 2025 Jan 07, 18:30

Options Alert: Why Novavax (NVAX) Could Be the Biotech Hero of Trump 2.0

Novavax Inc
Webhose 2025 Jan 07, 17:43

Novavax Target of Unusually High Options Trading (NASDAQ:NVAX)

Novavax Inc
Webhose 2025 Jan 07, 17:43

Novavax (NASDAQ:NVAX) Sees Large Volume Increase - Should You Buy?

Novavax Inc
Webhose 2025 Jan 07, 15:50

Why Vaccine Stocks, Lucid (LCID) Are Rallying

Novavax Inc
Webhose 2025 Jan 07, 04:54

Moderna stock gains on rising flu cases By Investing.com

Novavax Inc
Webhose 2025 Jan 06, 04:06

Vaccine developer stocks rise as flu activity escalates By Investing.com

Novavax Inc
Webhose 2025 Jan 05, 09:56

Novavax, Inc. (NASDAQ:NVAX) Director Sells $43,200.00 in Stock

Novavax Inc
Webhose 2025 Jan 03, 00:53

Novavax, Inc. (NASDAQ:NVAX) Director James F. Young Sells 4,600 Shares

Novavax Inc
Webhose 2025 Jan 03, 00:53

Rachel K. King Sells 4,150 Shares of Novavax, Inc. (NASDAQ:NVAX) Stock

Novavax Inc
Webhose 2025 Jan 03, 00:53

Novavax, Inc. (NASDAQ:NVAX) Director James F. Young Sells 5,400 Shares

Novavax Inc
Webhose 2025 Jan 02, 17:29

Novavax (NASDAQ:NVAX) Stock Price Up 6.6% - Should You Buy?

Novavax Inc
Webhose 2025 Jan 02, 13:48

Novavax director Rachel King sells $37,435 in stock By Investing.com

Novavax Inc
Webhose 2025 Jan 02, 13:46

Novavax director James Young sells shares worth $82,208 By Investing.com

Novavax Inc
Webhose 2025 Jan 02, 00:00

F James Young - Insider Monkey

Novavax Inc
Webhose 2025 Jan 02, 00:00

Novavax Inc (NVAX) - Insider Monkey

Novavax Inc
Webhose 2024 Dec 31, 05:40

Novavax completes $200 million facility sale to Novo Nordisk By Investing.com

Novavax Inc
Webhose 2024 Dec 30, 19:38

Novavax (NASDAQ:NVAX) Stock Price Down 5.8% - Time to Sell?

Novavax Inc
Webhose 2024 Dec 28, 08:28

Novavax, Inc. (NASDAQ:NVAX) Stock Holdings Boosted by Franklin Resources Inc.

Novavax Inc
Webhose 2024 Dec 24, 08:55

Geode Capital Management LLC Has $44.25 Million Stake in Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Dec 24, 08:03

Novavax, Inc. (NASDAQ:NVAX) Given Average Rating of "Hold" by Analysts

Novavax Inc

Latest news

Info

Spread

0.07

Spread (%)

0.7973 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Thursday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1411229824

Shares Outstanding

160184992

Earnings Date (Next)

2019-05-10

Div Yield

2019-05-10

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-2.18

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
view_all_instruments
Trustpilot
Live Chat